DIHEXA 5 mg

Dragon Pharma DIHEXA 5 mg Peptide for Cognitive Research

If you are looking to buy DIHEXA by Dragon Pharma, this research peptide represents one of the most advanced compounds currently studied for cognitive support and neural regeneration. DIHEXA is a synthetic oligopeptide derived from Angiotensin IV and designed to cross the blood-brain barrier, allowing it to interact directly with neurological pathways linked to memory and synaptic growth.

Unlike traditional nootropics that simply stimulate neurotransmitters, DIHEXA works by supporting structural changes in the brain. For athletes, bodybuilders, and high-performance individuals, maintaining optimal cognitive function and nervous system recovery can be just as important as physical training.

DIHEXA 5 mg Composition

DIHEXA (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic analog of Angiotensin IV. The compound was engineered to be orally active and capable of penetrating the blood-brain barrier, which allows it to interact with the hepatocyte growth factor (HGF) signaling system. Its molecular formula is C27H44N4O5.

Because of this mechanism, DIHEXA is categorized as a neurogenic peptide currently investigated in experimental studies related to synaptogenesis and neuronal repair.

Cognitive Support for Athletes

Intense training places significant demand on the central nervous system. Fatigue, reduced focus, and slower reaction times can all result from prolonged stress on the brain and CNS.

DIHEXA has attracted interest due to its potential to stimulate synaptogenesis — the formation of new neural connections. In theory, this may support improved cognitive clarity, learning capacity, and neuromuscular coordination, which are all valuable for athletes and bodybuilders seeking optimal performance.

Research Background

DIHEXA has been studied for its possible role in neurodegenerative conditions such as Alzheimer's disease. Its activity involves stimulation of the c-Met receptor through HGF signaling, which may encourage dendritic growth and neural network repair.

While ongoing research continues to evaluate its clinical potential, early laboratory findings suggest DIHEXA may support mechanisms involved in memory formation and neuronal regeneration.

Dosage (Men)

Important: DIHEXA is a research compound and not approved for medical use. The following information is based on research literature and anecdotal reports.

Typical experimental protocols range between 5–20 mg per day. Due to the compound's potency and long activity profile, many users report effective results with 5–10 mg daily. Administration methods may include oral, sublingual, or subcutaneous protocols depending on research design.

Dosage (Women)

Female users generally begin with lower experimental doses of 2.5–5 mg per day to evaluate tolerance. Gradual adjustment is recommended when exploring new peptide protocols.

Active Life

DIHEXA demonstrates a relatively long active life compared with many peptides. Rather than producing short-term stimulation, its effects are associated with gradual synaptic remodeling and cumulative neural support.

This longer activity profile is why once-daily administration is commonly referenced in experimental settings.

Possible Side Effects

Available research suggests DIHEXA is generally well tolerated in controlled environments. Reported effects may include mild headaches, temporary dizziness, or changes in sleep patterns as neurological activity adapts.

Because DIHEXA influences growth factor pathways, individuals should carefully review safety information before experimenting with this compound.

For additional research resources on neurodegenerative drug development, refer to the Alzheimer's Drug Discovery Foundation.

Contraindications / Precautions

DIHEXA should not be used by pregnant or nursing women. Individuals with a history of cancer or tumors potentially influenced by growth factors should avoid compounds affecting the HGF/c-Met pathway.

Always store peptides securely and keep them out of reach of children.

Overdosage

No confirmed cases of DIHEXA overdose have been documented in available literature. However, exceeding commonly referenced research ranges is unlikely to provide additional benefits and may increase risk of unwanted effects.

DIHEXA Stack / Research Combinations

Within peptide research communities, DIHEXA is often explored alongside other compounds associated with recovery and neurological support.

Examples include combining it with BPC 157 for systemic recovery research, or with Semax 5mg for cognitive performance protocols. Some experimental stacks also include MK-677 (Ibutamoren) when studying sleep quality and growth hormone signaling.

Package Presentation

Each vial contains 5 mg of lyophilized DIHEXA powder in a sterile 2 mL vial manufactured by Dragon Pharma. Lyophilization helps preserve peptide stability during storage and shipping.

Storage

Store the unopened vial in a cool, dry environment away from light. Refrigeration at 2–8°C is recommended for optimal stability.

After reconstitution with bacteriostatic water, the solution should remain refrigerated and used within several weeks.

Research Disclaimer

This product is intended for laboratory research and analytical purposes only. It is not approved for human consumption. Always verify the regulatory status of peptides within your jurisdiction before purchasing.